Good nursing care is the key to veno-occlusive disease (VOD) management
MRD negativity and its role as a predictor for CLL patient responses
Information is key: why patients need to be empowered to learn about their disease
Upcoming trials for DLBCL: R-CHOP with acalabrutinib and obinutuzumab with checkpoint inhibitor
The use of immunotherapies in combination for the treatment of multiple myeloma
Heinz Ludwig et al.